Comments

Collegium Pharmaceutical

Q: What sector and industry does Collegium Pharmaceutical (COLL) operate in?

Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

COLLNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Collegium Pharmaceutical (COLL) Forecast

News Earnings Collegium Pharmaceutical (COLL) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Collegium Pharmaceutical (NASDAQ:COLL) Stock Quotes, Forecast and News Summary

Collegium Pharmaceutical Stock (NASDAQ: COLL) stock price, news, charts, stock research, profile.

Open	$29.60
Close	-
Volume / Avg.	42.58K / 383.57K
Day Range	$29.02 - $29.78
52 Wk Range	24.61 - 42.29
Market Cap	$953.32M
P/E Ratio	12.64
Dividend Yield	-
Exchange	NASDAQ
RSI	25
Short Interest	23.86%
Days to Cover	23.61

Recent News

S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Why Collegium Pharmaceutical Shares Are Gaining Today

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial

Akanksha Bakshi

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a preliminary non-binding acquisition offer.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$29.60
Close	-
Volume / Avg.	42.58K / 383.57K
Day Range	$29.02 - $29.78
52 Wk Range	24.61 - 42.29
Market Cap	$953.32M
P/E Ratio	12.64
Dividend Yield	-
Exchange	NASDAQ
RSI	25
Short Interest	23.86%
Days to Cover	23.61

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Collegium Pharmaceutical (COLL) stock?

You can purchase shares of Collegium Pharmaceutical (NASDAQ:COLL) through any online brokerage.

View our list of the best stock brokerages

Who are Collegium Pharmaceutical (COLL) competitors?

Other companies in Collegium Pharmaceutical’s space includes: Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and Rapport Therapeutics (NASDAQ:RAPP).

What is the forecast, or price target, for Collegium Pharmaceutical (COLL) stock?

Collegium Pharmaceutical has a consensus price target of $42.00.

What is the current price for Collegium Pharmaceutical (COLL)?

The stock price for Collegium Pharmaceutical (NASDAQ: COLL) is $29.335 last updated November 18, 2024 at 10:09 AM EST.

Does Collegium Pharmaceutical (COLL) pay a dividend?

There are no upcoming dividends for Collegium Pharmaceutical.

When is Collegium Pharmaceutical (NASDAQ:COLL) reporting earnings?

Collegium Pharmaceutical’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Collegium Pharmaceutical (COLL) going to split?

There is no upcoming split for Collegium Pharmaceutical.

What sector and industry does Collegium Pharmaceutical (COLL) operate in?

Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.